Cargando…

A rare presentation of Sintilimab-induced swelling along the vessels: Case report

Immune-related adverse events are occasionally reported in Sintilimab treatment. This study reports a forward and reverse swelling case along the vein after infusion of Sintilimab. At present, swelling along the vascular direction during peripheral infusion are limitedly reported at home and abroad,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liqiong, Yu, Yang, Xia, Juan, Ning, Yanting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219706/
https://www.ncbi.nlm.nih.gov/pubmed/37233405
http://dx.doi.org/10.1097/MD.0000000000033859
_version_ 1785049070781333504
author Liu, Liqiong
Yu, Yang
Xia, Juan
Ning, Yanting
author_facet Liu, Liqiong
Yu, Yang
Xia, Juan
Ning, Yanting
author_sort Liu, Liqiong
collection PubMed
description Immune-related adverse events are occasionally reported in Sintilimab treatment. This study reports a forward and reverse swelling case along the vein after infusion of Sintilimab. At present, swelling along the vascular direction during peripheral infusion are limitedly reported at home and abroad, especially when choosing a vein with thick, elastic, and good blood return. PATIENT CONCERNS: A 56-year-old male who suffered from esophageal cancer and liver cancer and received albumin-bound paclitaxel and nedaplatin chemotherapy in combination with Sintilimab immunotherapy appeared swelling along the vessel after infusion of Sintilimab. The patient was punctured 3 times. DIAGNOSES: Sintilimab-induced vascular edema may be a side effect resulted from a combination of variables such as relatively poor vascular function of the patient, chemical extravasation, allergic skin reactions, venous valves, vascular intima, and diameter stenosis. Sintilimab rarely causes vascular edema only when drug allergic reaction is the underlying factor. As only a few cases of vascular edema caused by Sintilimab have been reported, causes to such a drug-induced vascular edema remained unclear. INTERVENTIONS: The swelling was controlled by an intravenous specialist nurse according to delayed extravasation treatment and the doctor anti-allergy treatment, but the uncertainty of repeated puncture and symptom diagnosis caused pain and anxiety to the patient and his family. OUTCOMES: The symptom of swelling was gradually relieved after the anti-allergic treatment. The patient completed the following drug infusion without discomfort after the third puncture. When the patient was discharged the next day, swelling in his both hands disappeared, and the patient had no anxiety or discomfort. LESSONS: The side effects of immunotherapy may accumulate over time. Early identification and appropriate nursing management are the keys to minimizing patients’ pain and anxiety. To effectively treat symptoms, nurses could benefit from quickly identifying the source of swelling.
format Online
Article
Text
id pubmed-10219706
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102197062023-05-27 A rare presentation of Sintilimab-induced swelling along the vessels: Case report Liu, Liqiong Yu, Yang Xia, Juan Ning, Yanting Medicine (Baltimore) 5700 Immune-related adverse events are occasionally reported in Sintilimab treatment. This study reports a forward and reverse swelling case along the vein after infusion of Sintilimab. At present, swelling along the vascular direction during peripheral infusion are limitedly reported at home and abroad, especially when choosing a vein with thick, elastic, and good blood return. PATIENT CONCERNS: A 56-year-old male who suffered from esophageal cancer and liver cancer and received albumin-bound paclitaxel and nedaplatin chemotherapy in combination with Sintilimab immunotherapy appeared swelling along the vessel after infusion of Sintilimab. The patient was punctured 3 times. DIAGNOSES: Sintilimab-induced vascular edema may be a side effect resulted from a combination of variables such as relatively poor vascular function of the patient, chemical extravasation, allergic skin reactions, venous valves, vascular intima, and diameter stenosis. Sintilimab rarely causes vascular edema only when drug allergic reaction is the underlying factor. As only a few cases of vascular edema caused by Sintilimab have been reported, causes to such a drug-induced vascular edema remained unclear. INTERVENTIONS: The swelling was controlled by an intravenous specialist nurse according to delayed extravasation treatment and the doctor anti-allergy treatment, but the uncertainty of repeated puncture and symptom diagnosis caused pain and anxiety to the patient and his family. OUTCOMES: The symptom of swelling was gradually relieved after the anti-allergic treatment. The patient completed the following drug infusion without discomfort after the third puncture. When the patient was discharged the next day, swelling in his both hands disappeared, and the patient had no anxiety or discomfort. LESSONS: The side effects of immunotherapy may accumulate over time. Early identification and appropriate nursing management are the keys to minimizing patients’ pain and anxiety. To effectively treat symptoms, nurses could benefit from quickly identifying the source of swelling. Lippincott Williams & Wilkins 2023-05-26 /pmc/articles/PMC10219706/ /pubmed/37233405 http://dx.doi.org/10.1097/MD.0000000000033859 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 5700
Liu, Liqiong
Yu, Yang
Xia, Juan
Ning, Yanting
A rare presentation of Sintilimab-induced swelling along the vessels: Case report
title A rare presentation of Sintilimab-induced swelling along the vessels: Case report
title_full A rare presentation of Sintilimab-induced swelling along the vessels: Case report
title_fullStr A rare presentation of Sintilimab-induced swelling along the vessels: Case report
title_full_unstemmed A rare presentation of Sintilimab-induced swelling along the vessels: Case report
title_short A rare presentation of Sintilimab-induced swelling along the vessels: Case report
title_sort rare presentation of sintilimab-induced swelling along the vessels: case report
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219706/
https://www.ncbi.nlm.nih.gov/pubmed/37233405
http://dx.doi.org/10.1097/MD.0000000000033859
work_keys_str_mv AT liuliqiong ararepresentationofsintilimabinducedswellingalongthevesselscasereport
AT yuyang ararepresentationofsintilimabinducedswellingalongthevesselscasereport
AT xiajuan ararepresentationofsintilimabinducedswellingalongthevesselscasereport
AT ningyanting ararepresentationofsintilimabinducedswellingalongthevesselscasereport
AT liuliqiong rarepresentationofsintilimabinducedswellingalongthevesselscasereport
AT yuyang rarepresentationofsintilimabinducedswellingalongthevesselscasereport
AT xiajuan rarepresentationofsintilimabinducedswellingalongthevesselscasereport
AT ningyanting rarepresentationofsintilimabinducedswellingalongthevesselscasereport